A method and apparatus for an inspection cell that allows contact lenses to be presented in a known orientation to an operator or vision system for inspection. The cell can be tipped to allow the inspected lens to be placed into a known pick-cup location upon passing inspection, or if the lens does not pass inspection, it can be discarded. The placement or discarding of the lens can be readily automated by selecting the rate at which the cell is tipped.

Patent
   7079239
Priority
Oct 07 2003
Filed
Oct 07 2003
Issued
Jul 18 2006
Expiry
Nov 09 2024
Extension
399 days
Assg.orig
Entity
Large
1
6
all paid
1. An inspection cell for optical devices comprising:
a block of optically transparent material having a concave bowl and a spillway formed in an exterior surface thereof, said spillway integrated with the bowl; and
a retainer for holding the block via a pivot point that allows the block to tip.
9. A method for inspecting lens comprising the steps of:
providing a block of optically transparent material having a concave bowl and a spillway formed in an exterior surface thereof, said spillway integrated with the bowl;
pivotally mounting the block within a retainer that allows the block to tip;
filling the bowl with a fluid;
placing a lens in the bowl; and
tipping the bowl to empty the fluid and the lens.
2. The inspection device of claim 1 further comprising a lens cup disposed at an end of the spillway for holding a lens.
3. The inspection device of claim 2 wherein the lens cup comprises a slot to expose a portion of an edge of the lens.
4. The inspection device of claim 1 wherein the block is made of optical glass.
5. The inspection device of claim 1 wherein the bowl has a concave aspheric shape and an opposed exterior surface has a convex aspheric shape.
6. The inspection device of claim 1 wherein the bowl has a concave spherical shape and an opposed exterior surface has a convex aspheric shape.
7. The inspection device of claim 1 wherein the bowl further comprises a lens incorporated into the bowl.
8. The inspection device of claim 1 wherein the block is made of optical acrylic.
10. The method of claim 9 wherein the step of providing further comprises providing a lens holder within the spillway.
11. The method of claim 10 wherein the step of tipping further comprises tipping the block at a rate such that the lens is caught within the lens holder.
12. The method of claim 10 wherein the step of tipping further comprises tipping the block at a rate such that the lens spill out the spillway without being caught by the lens holder.
13. The method of claim 10 wherein the step of tipping further comprises selectively tipping the block at a rate to alternatively catch the lens within the lens holder or not catch the lens within the lens holder in accordance with a signal that identifies the lens as either satisfactory or not satisfactory, respectively.

1. Field of the Invention

The present invention pertains to inspection cells for optical devices, and more particularly, to inspection cells for contact lenses that are adapted for easy or automated removal of lenses from the cell.

2. Description of the Prior Art

Prior art inspection of contact lenses is typically conducted on individual contact lenses within a separate flat bottom glass cell by manually placing the contact lens within the cell. These prior art inspection processes typically require that the contact lenses be manually flattened onto the bottom of the cell, cosmetically inspected using a comparator device, and then manually removed. Accepted lenses are manually placed into a packaging machine for further processing. It should be noted that prior art devices exist that include a non-articulated cell with a concave depression, the term non-articulated as used herein refers to a lack of features that provide for simple removal of the contact lens from the cell, or the device that holds the cell in place. The lack of articulated features within cells used by prior art inspection devices prevents the convenient movement of the contact lens without moving the device that holds the contact lens. These prior art inspection devices also fail to provide a mechanism for automated removal of the contact lenses from the cell, and do not even provide a simplified manual removal means.

Contact lenses have typically been transported from location to location in trays or vials. These trays or vials could be automatically filled with contact lenses but singulating the lenses after transportation has proved to be a quite difficult process to automate.

From the foregoing discussion, it should be apparent that there remains a need within the art for an inspection cell that is articulated to enable automated, or a simplified manual process, for removing the contact lenses from the cell once inspection is complete. There also remains a need within the art for a device that allows for simplified singulating of lenses after they have been inspected.

The present invention addresses the shortcoming within the prior art by providing an inspection cell that allows contact lenses to be presented in an orientation that is known to an operator or vision system for inspection. The cell can be tipped to allow the inspected lens to be placed into a known pick up location upon passing inspection, or if the lens does not pass inspection, it can be discarded. The placement or discarding of the lens can be readily automated by selecting the rate at which the cell is tipped.

These and other objects of the invention are provided by an inspection cell for optical devices having a block of essentially optically transparent material with a bowl formed therein, a spillway integrated with the bowl, a retainer for holding the block via a pivot point that allows the block to tip and a lens holder within the spillway.

FIGS. 1a and 1b are perspective views of the cell of the invention;

FIG. 2 is a cross sectional view illustrating a contact lens in the inspection cell of the invention;

FIG. 3a and FIG. 3b are cross sectional views of two alternative bowl shapes that can be used in accordance with the invention.

Referring to FIG. 1, a diagram of the water cell 5 of the invention that is designed to be filled with an appropriate amount of fluid, preferably water, the water cell 5 keeps a contact lens in a concave up position within a 20 mm diameter target area. Additionally, the water cell 5 of the invention is designed to take advantage of the relative densities of the fluid in the cell 5 (preferably water) and the material used to make the contact lenses to allow gravity to place the contact lens in the desired spot, or target area. The invention provides for the automatic return of a contact lens to the target area if the water cell 5 is disturbed during transportation of the water cell 5 or for any other reason. Once within the target area, incident light passing through the target area of the water cell 5 can be used to form an image the contact lens. The water cell 5 of the invention passes a sufficient amount of light (in terms of quantity and quality) to enable an image of the lens to be provided on a display screen to determine the lens quality. The water cell 5 of the invention is also capable of using two modes of operation for ejecting the lens after inspection. The ejection of a lens can be a complete, rapid ejection of unsatisfactory lenses or a slower, tipping of the water cell 5 for “good” lenses that are found to be satisfactory. The two modes allow lenses to be retrieved either manually or automatically. The water cell 5 of the invention allows for the provision of automated inspection devices that can discriminate between lenses that are found to be unsatisfactory and those lenses that are found to be satisfactory. Those lenses that are found to be unsatisfactory are disposed of by rapidly tipping the water cell 5, effectively discharging the unsatisfactory lens as the water flows out of the water cell 5. Those lenses that are found to be “good” or satisfactory, can be presented to a manipulator for final packaging by slowly tipping the water cell 5 and allowing the lens to be caught within a device articulated into the water cell 5.

The water cell 5 of the invention, as illustrated in FIG. 1, has various pieces that are required to perform the tasks previously described. A glass block 10 is formed, having an approximately 2 inch surface diameter bowl formed in the block 10. The bowl 12 can have a spherical or an aspherical shape. It has been found that a spherically shaped bowl 12 will tend to disperse light more than an aspherically shaped bowl 12, although both are specifically envisioned as useful embodiments of the present invention. Bowl 12 is formed within glass block 10 by conventional grinding processes. The glass used to form glass block 10 is preferably an optical quality glass, however, optical quality plastics and acrylics could also be used. The bowl 12 is filled with water during inspection. The lens is placed into the bowl 12 and becomes essentially centered in the bottom of the bowl 12 due to gravitational forces. As the lens sinks to the bottom of the bowl 12 it becomes centered and the water cell 5 assures the lens's proper placement within a 20 mm target area. Any lens displacement that occurs during movement of the water cell assembly is corrected within a few seconds as the lens settles back into the bottom of the bowl 12. Mated to the block 10 is a spillway 16. The spillway 16, as shown in FIG. 1, is designed to provide a seamless transition from the bowl 12 through which the lens and water can flow when the water cell 5 is tipped. At the end of the spillway is a pick-cup 18. The pick cup 18 is used as a position to present an accepted lens to a manipulator for transport to final packaging. When the water cell 5 is moved, depending upon the speed and total angular displacement of the water cell, the lens can either be thrown out of the bowl 12 via the spillway 16 with the water or strained out into the pick-cup 18 where a slot allows the lens to be grasped by a manual or an automated tweezer. The block 10 is held within a retaining device 14 via a pivot point 15 that allows the block to tip.

The bowl 12 has a profile that is chosen to accommodate the desirable characteristics of rapid settling behavior for a small diameter bowl and the desirable optical characteristics of a large diameter bowl. Preferably, the bottom of the block 10 has a plano-convex lens formed within it. This plano-convex lens is sized to correct for any optical distortion caused by the bowl 12 to water interface. The preferred embodiment will employ the bowl 12 that contains a plano-convex lens, however, it is specifically envisioned that the bottom on the block 10 can remain flat and an external lens can be used to correct for anticipated optical distortions instead of forming the plano-convex on the bottom of the block 10.

FIG. 2 is a cross-sectional drawing of the block 10 illustrating the liquid level 25 and lens 23 resting on the bottom of bowl 12. The bottom of bowl 12 is formed into a curved surface 22. Additionally, the bottom of block 10 has a curvature 20. It is specifically envisioned that curved surface 22 can function as a lens to correct for anticipated optical distortions. It is further envisioned that curvature 20 can also function as a lens alone or in combination with curved surface 22. Alternatively, if the bottom of block 10 is not a curved surface but a flat surface instead, the bowl 12 will have a tendency to disperse light, which is an undesirable effect but can be corrected with an external lens. Preferably, the optical characteristics of the inspection system will allow light to pass through the water cell 5 such that the light is collimated as it becomes incident upon the lens within the water cell 5. Curved surface 22 and curvature 20 are preferably designed to provide optical effects that compensate for refractive differences between the liquid (which is preferably water) and the material used to form block 10.

FIGS. 3a and 3b illustrate two additional examples of preferred embodiments having differently shaped bowls illustrative of the corresponding shapes to the plano-convex lenses that can be incorporated into the bottom of the glass water cell 5. FIG. 3a has an aspherical bowl 32 formed within block 30 and the bottom of block 30 has an aspherical shape. FIG. 3b illustrates a spherical bowl 42 formed within block 40 and the bottom of block 40 having an aspherical shape.

The new water cell provides the ability to create inspection systems that can convey, inspect and dispense a lens in an automatic fashion without manual user intervention. The cell is designed such that the spherical or aspherical indentation both accommodates automatic centering upon settling and a clear optical path for inspection. The spillway 16 and pick-cup 18 are configured such that with proper selection of tipping speed and amount, a lens can be completely evacuated from the cell or accurately presented to a robotic manipulator for further processing.

It is envisioned that the inspection systems that will be used with water cell 5 be specifically designed to accommodate the features that are be provided by water cell 5 of the present invention. Inspection systems used with the water cell 5 are provided with an opportunity to view a three dimensional image of the contact lens as it rests within the water cell 5. It is known that applying a narrow aperture to a lens increases the depth of field that can be obtained in imaging systems. Inspection systems are specifically envisioned that can be used with the water cell 5 of the invention that allow the contact lens to be measured as a true three-dimensional object. The three-dimensional images of the contact lens in the target area can be made by applying a collimated beam of light to the water cell 5 containing the contact lens, focusing the light that emerges through the water cell 5 with a lens having a narrow aperture and then reflecting the light from the lens with a narrow aperture towards a display screen. The bottom of the block 10 can have a curvature or can be flat with an external lens used to compensate for the change in refractive indices from glass to water.

The inspection cell containing the lens is either presented to a vision system or a lens inspector to determine if the lens is cosmetically acceptable. If the lens is deemed to be “good”, the inspection cell is slowly rotated about the pivot point so that the lens is carried down the spillway and becomes lodged in the “lens pocket” at the end of the spillway. A robotic actuator then removes the lens from the lens pocket and places it into the next process stage (such as a blister package).

The foregoing discussion describes the embodiments most preferred by the inventors. Variations of these embodiments will be readily apparent to those skilled in the art. Accordingly, the scope of the invention should be measured by the appended claims.

Bergendahl, Marc, Lewison, David, Puffer, Jr., Raymond H.

Patent Priority Assignee Title
7477366, Dec 07 2006 COOPERVISION INTERNATIONAL LIMITED Contact lens blister packages and methods for automated inspection of hydrated contact lenses
Patent Priority Assignee Title
5443152, Dec 21 1992 Johnson & Johnson Vision Products, Inc. Apparatus for carrying ophthalmic lenses
5786898, Aug 23 1996 Structure and method for centrifugal sedimentation particle size analysis of particles of lower density than their suspension medium
EP686459,
WO9981,
WO9504264,
WO3016855,
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 07 2003Bausch & Lomb Incorporated(assignment on the face of the patent)
May 25 2004BERGENDAHL, MARCBausch & Lomb IncorporatedASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0148000478 pdf
Jun 05 2004LEWISON, DAVIDBausch & Lomb IncorporatedASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0148000478 pdf
Jun 10 2004PUFFER, JR , RAYMOND H Bausch & Lomb IncorporatedASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0148000478 pdf
Mar 20 2008B&L VPLEX HOLDINGS, INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008BAUSCH & LOMB CHINA, INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008BAUSCH & LOMB REALTY CORPORATIONCREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008BAUSCH & LOMB SOUTH ASIA, INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008BAUSCH & LOMB TECHNOLOGY CORPORATIONCREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008Iolab CorporationCREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008RHC HOLDINGS, INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008SIGHT SAVERS, INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008WILMINGTON MANAGEMENT CORP CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B&L MINORITY DUTCH HOLDINGS LLCCREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008WILMINGTON PARTNERS L P CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B&L SPAF INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B&L FINANCIAL HOLDINGS CORP CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B&L CRL PARTNERS L P CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B&L CRL INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008WP PRISM INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008B & L DOMESTIC HOLDINGS CORP CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008Bausch & Lomb IncorporatedCREDIT SUISSESECURITY AGREEMENT0207330765 pdf
Mar 20 2008BAUSCH & LOMB INTERNATIONAL INC CREDIT SUISSESECURITY AGREEMENT0207330765 pdf
May 18 2012Credit Suisse AG, Cayman Islands BranchBausch & Lomb IncorporatedRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0287260142 pdf
May 18 2012Bausch & Lomb IncorporatedCITIBANK N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0287280645 pdf
May 18 2012EYEONICS, INC CITIBANK N A , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0287280645 pdf
Aug 05 2013CITIBANK N A , AS ADMINISTRATIVE AGENTBausch & Lomb IncorporatedRELEASE OF SECURITY INTEREST0309950444 pdf
Aug 05 2013CITIBANK N A , AS ADMINISTRATIVE AGENTWP PRISM INC N K A BAUSCH & LOMB HOLDINGS INC RELEASE OF SECURITY INTEREST0309950444 pdf
Aug 05 2013CITIBANK N A , AS ADMINISTRATIVE AGENTISTA PHARMACEUTICALSRELEASE OF SECURITY INTEREST0309950444 pdf
Aug 30 2013Bausch & Lomb IncorporatedGOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENTSECURITY AGREEMENT0311560508 pdf
Jan 08 2015GOLDMAN SACHS LENDING PARTNERS, LLCBARCLAYS BANK PLC, AS SUCCESSOR AGENTNOTICE OF SUCCESSION OF AGENCY0347490689 pdf
Jul 17 2017Bausch & Lomb IncorporatedThe Bank of New York MellonSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0432510932 pdf
Feb 13 2018LABORATOIRE CHAUVIN S A S THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018ONPHARMA INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018VALEANT PHARMACEUTICALS IRELAND LIMITEDTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018VALEANT PHARMACEUTICALS LUXEMBOURG S A R L THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018VALEANT PHARMA POLAND SP Z O O THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018WIRRA IP PTY LIMITEDTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018VALEANT PHARMACEUTICALS NORTH AMERICA LLCTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Valeant Pharmaceuticals InternationalTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018VALEANT CANADA LPTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Technolas Perfect Vision GmbHTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Valeant Pharmaceuticals InternationalBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018VALEANT CANADA LPBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018Technolas Perfect Vision GmbHBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018SYNERGETICS USA, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018SOLTA MEDICAL, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018SANTARUS, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018Salix Pharmaceuticals, LtdBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018PRECISION DERMATOLOGY, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018ORAPHARMA, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018Medicis Pharmaceutical CorporationBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018LABORATOIRE CHAUVIN S A S BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018ECR PHARMACEUTICALS CO , INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018DOW PHARMACEUTICAL SCIENCES, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018COMMONWEALTH LABORATORIES, LLCBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018BAUSCH & LOMB PHARMA HOLDINGS CORP BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018Bausch & Lomb IncorporatedBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018VALEANT PHARMACEUTICALS NORTH AMERICA LLCBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018WIRRA IP PTY LIMITEDBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018VALEANT PHARMA POLAND SP Z O O BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018SYNERGETICS USA, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018SOLTA MEDICAL, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018SANTARUS, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Salix Pharmaceuticals, LtdTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018PRECISION DERMATOLOGY, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018ORAPHARMA, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018ONPHARMA INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Medicis Pharmaceutical CorporationTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018ECR PHARMACEUTICALS CO , INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018DOW PHARMACEUTICAL SCIENCES, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018COMMONWEALTH LABORATORIES, LLCTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018BAUSCH & LOMB PHARMA HOLDINGS CORP THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018Bausch & Lomb IncorporatedTHE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018ATON PHARMA, INC THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440634 pdf
Feb 13 2018VALEANT PHARMACEUTICALS IRELAND LIMITEDBARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018VALEANT PHARMACEUTICALS LUXEMBOURG S A R L BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Feb 13 2018ATON PHARMA, INC BARCLAYS BANK PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0454440299 pdf
Mar 08 2019Bausch & Lomb IncorporatedTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019SALIX PHARMACEUTICALS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019PRECISION DERMATOLOGY, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019ORAPHARMA, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019SANTARUS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019Medicis Pharmaceutical CorporationTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019SOLTA MEDICAL, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019BAUSCH HEALTH US, LLCTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Mar 08 2019BAUSCH HEALTH AMERICAS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0485560758 pdf
Jun 08 2021PRECISION DERMATOLOGY, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021BAUSCH HEALTH AMERICAS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021ORAPHARMA, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021SANTARUS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021Medicis Pharmaceutical CorporationTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021SOLTA MEDICAL, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021Bausch & Lomb IncorporatedTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021BAUSCH HEALTH US, LLCTHE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Jun 08 2021SALIX PHARMACEUTICALS, INC THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0568110814 pdf
Feb 10 2022ORAPHARMA, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022Bausch & Lomb IncorporatedThe Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022BAUSCH HEALTH US, LLCThe Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022SOLTA MEDICAL, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022Medicis Pharmaceutical CorporationThe Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022PRECISION DERMATOLOGY, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022BAUSCH HEALTH AMERICAS, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022SANTARUS, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
Feb 10 2022SALIX PHARMACEUTICALS, INC The Bank of New York MellonSECURITY AGREEMENT0591210001 pdf
May 10 2022Bausch & Lomb IncorporatedCITIBANK, N A AS COLLATERAL AGENTPATENT SECURITY AGREEMENT0599130548 pdf
Oct 18 2022The Bank of New York MellonBausch & Lomb IncorporatedOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 048556 0758 0618720484 pdf
Oct 18 2022The Bank of New York MellonThe United States of America, as represented by the Secretary, Department of Health and Human ServicesOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 0618720295 pdf
Oct 18 2022The Bank of New York MellonTechnolas Perfect Vision GmbHOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 0618720295 pdf
Oct 18 2022The Bank of New York MellonLABORATOIRE CHAUVIN S A S OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 0618720295 pdf
Oct 18 2022The Bank of New York MellonBausch & Lomb IncorporatedOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 045444 0634 0618720295 pdf
Oct 18 2022The Bank of New York MellonBausch & Lomb IncorporatedOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 056811 0814 0618720669 pdf
Oct 18 2022The Bank of New York MellonBausch & Lomb IncorporatedOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 059121 0001 0618730001 pdf
Oct 18 2022The Bank of New York MellonBAUSCH HEALTH COMPANIES INC OMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 048556 0758 0618720484 pdf
Oct 18 2022The Bank of New York MellonTechnolas Perfect Vision GmbHOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 048556 0758 0618720484 pdf
Oct 18 2022The Bank of New York MellonThe United States of America, as represented by the Secretary, Department of Health and Human ServicesOMNIBUS PATENT SECURITY RELEASE AGREEMENT REEL FRAME 048556 0758 0618720484 pdf
Oct 19 2022BARCLAYS BANK PLCBausch & Lomb IncorporatedRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 034749 0689 0617780146 pdf
Oct 19 2022BARCLAYS BANK PLCUniversity of RochesterRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 034749 0689 0617780146 pdf
Oct 19 2022BARCLAYS BANK PLCBausch & Lomb IncorporatedRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 031156 0508 0617780446 pdf
Oct 19 2022BARCLAYS BANK PLCLABORATOIRE CHAUVIN S A S RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 0617790001 pdf
Oct 19 2022BARCLAYS BANK PLCThe United States of America, as represented by the Secretary, Department of Health and Human ServicesRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 0617790001 pdf
Oct 19 2022BARCLAYS BANK PLCPF Consumer Healthcare 1 LLCRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 0617790001 pdf
Oct 19 2022BARCLAYS BANK PLCTechnolas Perfect Vision GmbHRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 0617790001 pdf
Oct 19 2022BARCLAYS BANK PLCBausch & Lomb IncorporatedRELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS REEL FRAME 045444 0299 0617790001 pdf
Sep 29 2023Bausch & Lomb IncorporatedCITIBANK, N A , AS NOTES COLLATERAL AGENTPATENT SECURITY AGREEMENT0651200086 pdf
Date Maintenance Fee Events
Jan 04 2010M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Jan 08 2014M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Dec 20 2017M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Jul 18 20094 years fee payment window open
Jan 18 20106 months grace period start (w surcharge)
Jul 18 2010patent expiry (for year 4)
Jul 18 20122 years to revive unintentionally abandoned end. (for year 4)
Jul 18 20138 years fee payment window open
Jan 18 20146 months grace period start (w surcharge)
Jul 18 2014patent expiry (for year 8)
Jul 18 20162 years to revive unintentionally abandoned end. (for year 8)
Jul 18 201712 years fee payment window open
Jan 18 20186 months grace period start (w surcharge)
Jul 18 2018patent expiry (for year 12)
Jul 18 20202 years to revive unintentionally abandoned end. (for year 12)